CADAS138 emerges as a novel therapeutic target in the realm of neurodegenerative diseases. Preclinical studies reveal significant potential for CADAS138-targeted therapies to alleviate disease progression. Researchers https://shaniaddad866058.blog5.net/90353697/a-potential-therapeutic-strategy